Take action on access to compounded medications

New Academy website makes it easier than ever for members to advocate for change

By Sabra Sullivan, MD, PhD
Chair of the AADA’s Council on Government Affairs and Health Policy

Many members have asked the Academy to make it easier to take grassroots action on legislation impacting our specialty. As someone who has witnessed firsthand the awesome power of advocacy, I’m delighted to announce that the Academy has launched a new web tool that will make contacting your legislators as simple as a click of a button!

The new Take Action site allows members to support advocacy alerts in less than a minute.

This month, the Academy launched TakeAction.aad.org, a new, dynamic web tool on  AAD.org that replaces the Dermatology Action Network. Take Action is hosted on the Academy's website, so there’s no longer a need for a separate login. Simply use your aad.org login to access all advocacy alerts.

I encourage all members to visit Take Action this month and take part in our current calls to action.

Take action on office-use compounded medications

One important alert on Take Action relates to office-use compounded medications. The FDA has prohibited Section 503A traditional compounding pharmacies from distributing office-use compounded medications to physician practices without a patient-specific prescription. State pharmacy boards are also taking similar actions in response to FDA’s interpretation of the DQSA. As a result, physicians must now obtain office-use compounded medications from Section 503B outsourcing facilities, which are listed on the FDA Registered Outsourcing Facilities page. Or, physicians must submit patient-specific prescriptions to Section 503A traditional compounding pharmacies before the compounded medications are dispensed.

The Academy is asking members to urge legislators to support H.R. 2871, the Preserving Patient Access to Compounded Medications Act, which clarifies congressional intent of the Drug Quality & Security Act (DQSA) regarding physician access to office-use compounded medications. The legislation affirms that office use would be permitted if the medication is compounded by a licensed pharmacist or physician prior to receipt of a valid prescription or order in states that allow office use. Simply visit Take Action to submit your letter of support. It will take you less than a minute to lend your voice to this important issue.

Other features of Take Action

In addition to access to current advocacy alerts, Take Action allows members to easily find their legislators and to get involved in advocacy in a myriad of ways, including:

Help provide a united voice to local, state, and national legislators on our top issues! Leverage the power of our new Take Action site to protect our patients and our specialty.

New resources to battle compounding issues

In 2013, Congress passed the Drug Quality and Security Act (DQSA), which tightened federal oversight over certain compounding facilities. To implement the law, the FDA has issued draft and final guidance documents on compounding by traditional compounding pharmacies as well as physicians who compound in office.

The Academy recently launched a website to help members keep current with compounding issues threatening patient care and the specialty. The site offers practice tips on how physicians can advocate for access to compounded medications.

visit the site